Hospital Universitario a Coruna

A Coruña 15006

2 studies enrolling now · 13 studies all time

What they study most

Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC), Ankylosing Spondyloarthritis, Carcinoma, Non-Small-Cell Lung, Covid19, Heart Failure, Hemophilia A, Hemophilia B, Lupus Erythematosus, Systemic, Metastatic Melanoma, Pancreatic Neoplasms, Psoriatic Arthritis, Renal Cell Carcinoma

Studies at this site

• Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors — Recruiting now
• Alleviant ALLAY-HFrEF Study — Enrolling by invitation
• TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations — Running, not enrolling
• Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma — Completed
• Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE — Completed
• A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus — Completed
• A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma — Stopped early
• A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer — Stopped early
• Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis — Completed
• Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis — Completed
• PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis — Completed
• Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy — Completed
• Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) — Completed